#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pemphigoid Haemophilia Non-small cell lung cancer Pulmonary alveolar haemorrhage Metachromatic leukodystrophy Heart disease congenital Germ cell cancer Cardiomyopathy Acute graft versus host disease Bile acid synthesis disorder Duchenne muscular dystrophy Hepatobiliary cancer Mixed-type liposarcoma Acquired C1 inhibitor deficiency Palmoplantar pustulosis More trials…

    Learn about Rare Diseases

    Primary biliary cholangitis Choroid melanoma – Life with Disease Rhabdomyosarcoma recurrent – Trials in Disease Metachromatic leukodystrophy – Treatment Shprintzen-Goldberg syndrome – Basic Information Paroxysmal nocturnal haemoglobinuria – Diagnostics Adrenocortical carcinoma – Trials in Disease Rhabdomyosarcoma – Basic Information Synovial sarcoma recurrent – Treatment VEXAS syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IADADEMSTAT Progesterone, Micronised Juniper Berry Oil Levocetirizine Dihydrochloride Pantothenate Sodium Glyceryl Trinitrate POLYMYXIN B SULFATE VHB937 Vimseltinib Icatibant [18F]CPFPX Mycophenolic Acid Pp1815 SULBACTAM SODIUM Benfotiamine GRNA-001 Pemetrexed Cenerimod Rintatolimod Repotrectinib More therapies…

    Learn about Your Condition

    Vertebrobasilar stroke Onychomycosis Lupus nephritis Dermatitis atopic Body mass index increased Vomiting Alopecia areata Asymptomatic HIV infection Retinoblastoma Uterine leiomyosarcoma Pyelonephritis Factor VIII deficiency Diabetic nephropathy Cardiac failure Hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. PPX Pneumologische Praxis Xanthopoulos

PPX Pneumologische Praxis Xanthopoulos

Karl-Liebknecht-Str. 21, Fürstenwalde, 15517, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Long-term safety study of dexpramipexole tablets in patients with severe eosinophilic asthma who completed EXHALE-2 or EXHALE-3 trials

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dexpramipexole Dihydrochloride Monohydrate
    Bulgaria Czechia Germany Italy Poland Romania +1

  • Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Dexpramipexole Dihydrochloride Monohydrate
    • Salbutamol Sulfate Ph. Eur.
    • Budesonide
    Austria Croatia Czechia France Germany Hungary +3

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Formoterol Fumarate
    • Budesonide
    • Formoterol Fumarate Dihydrate
    Czechia Germany Greece Portugal Slovakia

  • Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Beclometasone Dipropionate Anhydrous
    • Formoterol Fumarate Dihydrate
    • Glycopyrronium Bromide
    Bulgaria Czechia Germany Greece Hungary Italy +5

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!